School of Social and Political Sciences and Sydney Centre for Healthy Societies, The University of Sydney, Australia.
School of Social and Political Sciences and Sydney Centre for Healthy Societies, The University of Sydney, Australia.
Soc Sci Med. 2021 Sep;285:114298. doi: 10.1016/j.socscimed.2021.114298. Epub 2021 Aug 4.
Antimicrobial resistance (AMR) is now recognised as a social, cultural, economic and political phenomenon, positioning the social sciences as central in responding to this global health threat. Yet efforts to address AMR within hospital settings, for example through antimicrobial stewardship (AMS) programs, continue to focus primarily on the prescribing practices of individual clinicians, often with little effect. There has been less attention to the role of healthcare administration, and managerialism therein, in explaining the limited progress to date in reining in antimicrobial misuse. To explore this, drawing on interviews with senior executives and managers from two Australian hospitals, we examine how these stakeholders navigate between management practice and AMR solutions, revealing that antimicrobial optimisation is frequently obscured by accountability structures attuned to other agendas. This has led, we argue, to the institutionalisation of micro-improvements that frequently 'tick the box' of having an AMS program, yet do little to effectively counteract rising AMR. Our analysis illustrates how sociological attention to the structural and ideological settings within which prescribing behaviour is carried out will be crucial to any attempts to successfully rein in AMR.
抗菌药物耐药性(AMR)现在被认为是一种社会、文化、经济和政治现象,使社会科学在应对这一全球健康威胁方面处于核心地位。然而,在医院环境中应对 AMR 的努力,例如通过抗菌药物管理(AMS)计划,仍然主要集中在个别临床医生的处方实践上,往往效果甚微。人们对医疗保健管理以及其中的管理主义在解释迄今为止在控制抗菌药物滥用方面所取得的有限进展方面的作用关注较少。为了探讨这一点,我们借鉴了澳大利亚两家医院的高级管理人员和经理的访谈,研究了这些利益相关者如何在管理实践和 AMR 解决方案之间进行权衡,揭示了抗菌药物优化经常被适应其他议程的问责制结构所掩盖。我们认为,这导致了微观改进的制度化,这些改进经常“符合”有 AMS 计划的要求,但对抗菌药物耐药性的上升几乎没有起到有效的遏制作用。我们的分析说明了对处方行为开展的结构性和意识形态环境进行社会学关注,对于成功控制 AMR 的任何尝试都将是至关重要的。